Sfoglia per RIVISTA
SCIENTIFIC REPORTS
Collezione ASL Biella

  

Items : 5

Characterizing the patient experience of physical restraint in psychiatric settings via a linguistic, sentiment, and metaphor analysis. in Scientific reports / Sci Rep. 2025 Jan 15;15(1):2111. doi: 10.1038/s41598-024-83999-9.

2025
ASL Biella
ASL VCO

Bosia M; Bischetti L; Mangiaterra V; Frau F; Pompei C; Santinon P; Ferraris S; Durbano F; Cavallotti S; Cigognini AC; Alecci E; Toschi L; Scalingi B; Barattieri di San Pietro C; Nichini C; Peschi G; Politi P; Bambini V;

Plasma microRNA ratios associated with breast cancer detection in a nested case-control study from a mammography screening cohort. in Scientific reports / Sci Rep. 2023 Jul 25;13(1):12040. doi: 10.1038/s41598-023-38886-0.

2023
AOU Città della Salute di Torino
ASL Biella

Chiorino G; Petracci E; Sehovic E; Gregnanin I; Camussi E; Mello-Grand M; Ostano P; Riggi E; Vergini V; Russo A; Berrino E; Ortale A; Garena F; Venesio T; Gallo F; Favettini E; Frigerio A; Matullo G; Segnan N; Giordano L;

Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy. in Scientific reports / Sci Rep. 2020 Jan 31;10(1):1918. doi: 10.1038/s41598-020-58486-6.

2020
ASL Biella

Ruzzo A; Graziano F; Galli F; Galli F; Rulli E; Lonardi S; Ronzoni M; Massidda B; Zagonel V; Pella N; Mucciarini C; Labianca R; Ionta MT; Bagaloni I; Veltri E; Sozzi P; Barni S; Ricci V; Foltran L; Nicolini M; Biondi E; Bramati A; Turci D; Lazzarelli S; Verusio C; Bergamo F; Sobrero A; Frontini L; Magnani M; et alii...

Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy. in Scientific reports / Sci Rep. 2019 Aug 8;9(1):11527. doi: 10.1038/s41598-019-47627-1.

2019
ASL Biella

Ruzzo A; Graziano F; Galli F; Galli F; Rulli E; Lonardi S; Ronzoni M; Massidda B; Zagonel V; Pella N; Mucciarini C; Labianca R; Ionta MT; Bagaloni I; Veltri E; Sozzi P; Barni S; Ricci V; Foltran L; Nicolini M; Biondi E; Bramati A; Turci D; Lazzarelli S; Verusio C; Bergamo F; Sobrero A; Frontini L; Magnani M; et alii...

Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients. in Scientific reports / Sci Rep. 2014 Nov 5;4:6828. doi: 10.1038/srep06828.

2014
ASL Biella

Ruzzo A; Graziano F; Galli F; Giacomini E; Floriani I; Galli F; Rulli E; Lonardi S; Ronzoni M; Massidda B; Zagonel V; Pella N; Mucciarini C; Labianca R; Ionta MT; Veltri E; Sozzi P; Barni S; Ricci V; Foltran L; Nicolini M; Biondi E; Bramati A; Turci D; Lazzarelli S; Verusio C; Bergamo F; Sobrero A; Frontini L; et alii...